Pharmaceuticals

Beximco Pharmaceuticals has started the export of its third item -Methocarbamol (500mg and 700mg) to the United States. Following the successful marketing of Carvedilol and Sotalol in August 2016 and November 2017, respectively in the world’s...

Biogen Inc struck a $1 billion neurology drug development deal with Ionis Pharmaceuticals on Friday, expanding a partnership that developed the company’s potential blockbuster drug for spinal muscular atrophy. Biogen’s shares, however, fell about 2 percent...

Sanofi is investing €350 million for the construction of a new state-of-the-art vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters in Toronto, Ontario. The investment bolsters the company’s Canadian operations and its commitment to advancing...

GlaxoSmithKline has quit the race to buy Pfizer’s consumer healthcare business, endangering an auction the U.S. drugmaker hoped would bring in as much as $20 billion. It was not immediately clear whether there were other offers...

Novartis announced that it is teaming up with scientists from the Wyss Institute for Biologically Inspired Engineering at Harvard University and the Dana-Farber Cancer Institute to develop biomaterial systems for its portfolio of immuno-oncology therapies. The...

Lundbeck develops and distributes drugs for the neurological and psychological disease. Lundbeck agreed to buy Prexton Therapeutics, a specialist in treatments for brain disorders, in a deal potentially worth $1.1 billion, the Danish drugmaker said on...

Biogen said it plans to start mid-stage tests on the drug, which is being developed to treat cognitive impairment associated with schizophrenia. Biogen Inc said on Monday it would buy Pfizer Inc’s experimental treatment for a...

The studies will blend virtual and traditional models, with increasing degrees of decentralization towards a mostly “site-less” model. Novartis was an early investor in Science 37 and together we have already initiated virtual trials for a cluster...

The investment round was led by aMoon Fund, the investment arm of Check Point Software Technologies co-founder Marius Nacht. The round also included Hong Kong-based Horizons Ventures and Nir Kalkstein, founder of high-speed trading firm Final...

Diarrheal diseases are one of the leading causes of childhood mortality globally, resulting in approximately 525,000 deaths each year and cryptosporidiosis is the second leading cause of infectious diarrhea in children under 2 years of age....